BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Xeris Biopharma Holdings
XERS
$1.53B
| $18K | ﹤0.01% |
9,234
+6,162
| +201% | +$26.5K |
|
|
ACOR
3777
DELISTED
Acorda Therapeutics
ACOR
| $18K | ﹤0.01% |
161
-10
| -6% | -$1.97K |
|
|
PRGX
3778
DELISTED
PRGX Global, Inc.
PRGX
| $17.9K | ﹤0.01% |
6,381
+3,441
| +117% | +$13K |
|
3779
Natural Gas Services Group
NGS
$476M
| $17.9K | ﹤0.01% |
4,003
+869
| +28% | +$8.15K |
|
3780
Siebert Financial
SIEB
$77.7M
| $17.8K | ﹤0.01% |
2,462
+1,376
| +127% | +$11K |
|
|
INWK
3781
DELISTED
InnerWorkings, Inc.
INWK
| $17.7K | ﹤0.01% |
15,161
+3,317
| +28% | +$11.8K |
|
3782
iShares US Healthcare ETF
IYH
$3.77B
| $17.7K | ﹤0.01% |
470
-190
| -29% | -$7.81K |
|
3783
LiveOne
LVO
$58.4M
| $17.6K | ﹤0.01% |
1,116
+531
| +91% | +$7.67K |
|
3784
Aldeyra Therapeutics
ALDX
$91.7M
| $17.5K | ﹤0.01% |
7,099
+3,287
| +86% | +$14.8K |
|
|
PHX
3785
DELISTED
PHX Minerals
PHX
| $17.5K | ﹤0.01% |
4,740
+1,114
| +31% | +$7.43K |
|
3786
Vanguard Dividend Appreciation ETF
VIG
$115B
| $17.5K | ﹤0.01% |
169
-674
| -80% | -$80.4K |
|
|
YELL
3787
DELISTED
Yellow Corporation Common Stock
YELL
| $17.4K | ﹤0.01% |
10,381
+2,253
| +28% | +$4.92K |
|
3788
Tempest Therapeutics
TPST
$18.9M
| $17.1K | ﹤0.01% |
17
+10
| +143% | +$14.6K |
|
3789
Avalo Therapeutics
AVTX
$1.04B
| $17K | ﹤0.01% |
2
+1
| +100% | +$10.6K |
|
3790
Ring Energy
REI
$347M
| $17K | ﹤0.01% |
25,740
+7,356
| +40% | +$13.1K |
|
3791
Antero Resources
AR
$11.3B
| $16.9K | ﹤0.01% |
23,729
-523,831
| -96% | -$876K |
|
|
SOLY
3792
DELISTED
Soliton, Inc.
SOLY
| $16.6K | ﹤0.01% |
2,045
+1,220
| +148% | +$13.8K |
|
3793
Legacy Housing
LEGH
$705M
| $16.5K | ﹤0.01% |
1,786
+623
| +54% | +$8.49K |
|
3794
CALL
Simon Property Group
SPG
$71.8B
| $16.5K | ﹤0.01% |
3
-33
| -92% | -$3.95K |
|
|
IMDX
3795
Insight Molecular Diagnostics
IMDX
$129M
| $16.5K | ﹤0.01% |
336
+188
| +127% | +$9.22K |
|
3796
AstroNova
ALOT
$227M
| $16.4K | ﹤0.01% |
2,118
+1,158
| +121% | +$13.4K |
|
|
HALL
3797
DELISTED
Hallmark Financial Services, Inc.
HALL
| $16.2K | ﹤0.01% |
402
+90
| +29% | +$12.2K |
|
3798
Bassett Furniture
BSET
$171M
| $16.2K | ﹤0.01% |
2,972
+656
| +28% | +$7.28K |
|
3799
Lee Enterprises
LEE
$181M
| $16.2K | ﹤0.01% |
1,648
+370
| +29% | +$5.28K |
|
|
NGD
3800
DELISTED
New Gold Inc
NGD
| $16.2K | ﹤0.01% |
31,680
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.